Dudediligence.

GRAIL, Inc

GRALNASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$28.7MSep ’24$38.3MDec ’24$31.8MMar ’25$35.5MJun ’25$36.2MSep ’25$43.6MDec ’25$40.8MMar ’26$44.7MJun ’26
Net income, by quarter
−$125.7MSep ’24−$97.1MDec ’24−$106.2MMar ’25−$114.0MJun ’25−$89.0MSep ’25−$99.2MDec ’25−$93.2MMar ’26−$110.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$55.5M$93.1M$125.6M$147.2M
Operating incomenone on file−$5.44B−$1.52B−$2.19B−$562.2M
Net incomenone on file−$5.40B−$1.47B−$2.03B−$408.4M
Operating cash flownone on file−$561.3M−$595.8M−$577.2M−$299.0M
Free cash flownone on file−$584.2M−$608.7M−$582.4M−$299.9M
Cash$226.0M$241.6M$97.3M$214.2M$249.7M
Shares outstandingnone on file31.0M033.9M40.3M